In addition, genetic alterations in CDK4 pathway components (CDK4, CCND1, and CDKN2A), which are particularly common in Asians, have been associated with innate resistance to PD-1 blockade in patients with acral melanoma (93). The gene discussed is CCND1; the disease is acral lentiginous melanoma.